299 related articles for article (PubMed ID: 15337704)
21. Statins and progression of calcified aortic stenosis.
Chua D; Kalb K
Ann Pharmacother; 2006 Dec; 40(12):2195-9. PubMed ID: 17132803
[TBL] [Abstract][Full Text] [Related]
22. The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis.
Dimitrow PP; Jawień M; Gackowski A
J Heart Valve Dis; 2011 Jan; 20(1):18-22. PubMed ID: 21404893
[TBL] [Abstract][Full Text] [Related]
23. [Medical treatments in aortic stenosis: role of statins and angiotensin-converting enzyme inhibitors].
Davicević Z; Tavciovski D; Matunović R
Med Pregl; 2010; 63(1-2):82-5. PubMed ID: 20873315
[TBL] [Abstract][Full Text] [Related]
24. HMG CoA reductase inhibitor (statin) and aortic valve calcium.
Shavelle DM; Takasu J; Budoff MJ; Mao S; Zhao XQ; O'Brien KD
Lancet; 2002 Mar; 359(9312):1125-6. PubMed ID: 11943265
[TBL] [Abstract][Full Text] [Related]
25. Do statins slow the progression of aortic valve stenosis?
Tourmousoglou CE; Lalos S; Psarros T
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):684-9. PubMed ID: 18413348
[TBL] [Abstract][Full Text] [Related]
26. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis.
Capoulade R; Clavel MA; Mathieu P; Côté N; Dumesnil JG; Arsenault M; Bédard E; Pibarot P
Eur J Clin Invest; 2013 Dec; 43(12):1262-72. PubMed ID: 24117162
[TBL] [Abstract][Full Text] [Related]
27. A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography.
Antonini-Canterin F; Corrado G; Faggiano P; Popescu BA; Carerj S; La Carrubba S; Zuppiroli A; Nicolosi GL
J Cardiovasc Med (Hagerstown); 2006 Jul; 7(7):464-9. PubMed ID: 16801806
[TBL] [Abstract][Full Text] [Related]
28. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.
Bellamy MF; Pellikka PA; Klarich KW; Tajik AJ; Enriquez-Sarano M
J Am Coll Cardiol; 2002 Nov; 40(10):1723-30. PubMed ID: 12446053
[TBL] [Abstract][Full Text] [Related]
29. Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug.
Goel SS; Tuzcu EM; Agarwal S; Aksoy O; Krishnaswamy A; Griffin BP; Svensson LG; Kapadia SR
Am J Cardiol; 2011 Nov; 108(10):1458-62. PubMed ID: 22040719
[TBL] [Abstract][Full Text] [Related]
30. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.
Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
J Am Coll Cardiol; 2012 Jul; 60(3):216-23. PubMed ID: 22789885
[TBL] [Abstract][Full Text] [Related]
31. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
32. Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis.
Loomba RS; Arora R
Am J Ther; 2010; 17(4):e110-4. PubMed ID: 19417587
[TBL] [Abstract][Full Text] [Related]
33. [Statins in aortic stenosis].
Dejanović J; Ivanov I
Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
[TBL] [Abstract][Full Text] [Related]
34. Do bisphosphonates slow the progression of aortic stenosis?
Aksoy O; Cam A; Goel SS; Houghtaling PL; Williams S; Ruiz-Rodriguez E; Menon V; Kapadia SR; Tuzcu EM; Blackstone EH; Griffin BP
J Am Coll Cardiol; 2012 Apr; 59(16):1452-9. PubMed ID: 22497825
[TBL] [Abstract][Full Text] [Related]
35. Prevention of calcific aortic valve stenosis-fact or fiction?
Cawley PJ; Otto CM
Ann Med; 2009; 41(2):100-8. PubMed ID: 18720096
[TBL] [Abstract][Full Text] [Related]
36. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.
Dalsgaard M; Iversen K; Kjaergaard J; Grande P; Goetze JP; Clemmensen P; Hassager C
Am Heart J; 2014 Feb; 167(2):226-34. PubMed ID: 24439984
[TBL] [Abstract][Full Text] [Related]
37. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial.
Chan KL; Teo K; Tam J; Dumesnil JG;
Am Heart J; 2007 Jun; 153(6):925-31. PubMed ID: 17540192
[TBL] [Abstract][Full Text] [Related]
38. Is it time to prescribe statins to patients with calcified aortic stenosis?
Rashidi A; Adler DS; Casscells W; Madjid M
Am Heart J; 2005 Jul; 150(1):41-5. PubMed ID: 16084149
[TBL] [Abstract][Full Text] [Related]
39. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.
Chan KL; Teo K; Dumesnil JG; Ni A; Tam J;
Circulation; 2010 Jan; 121(2):306-14. PubMed ID: 20048204
[TBL] [Abstract][Full Text] [Related]
40. Medical therapy for calcific aortic stenosis.
Salas MJ; Santana O; Escolar E; Lamas GA
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):133-8. PubMed ID: 21828284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
